Your browser doesn't support javascript.
loading
Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
Elakad, Omar; Lois, Anna-Maria; Schmitz, Katja; Yao, Sha; Hugo, Sara; Lukat, Laura; Hinterthaner, Marc; Danner, Bernhard C; von Hammerstein-Equord, Alexander; Reuter-Jessen, Kirsten; Schildhaus, Hans-Ulrich; Ströbel, Philipp; Bohnenberger, Hanibal.
Afiliación
  • Elakad O; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Lois AM; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Schmitz K; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Yao S; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Hugo S; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Lukat L; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Hinterthaner M; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Göttingen, Germany.
  • Danner BC; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Göttingen, Germany.
  • von Hammerstein-Equord A; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Göttingen, Germany.
  • Reuter-Jessen K; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Schildhaus HU; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Ströbel P; Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Bohnenberger H; Institute of Pathology, University Medical Center, Göttingen, Germany.
Cancer Med ; 9(10): 3574-3583, 2020 05.
Article en En | MEDLINE | ID: mdl-32207251
BACKGROUND: Targeting fibroblast growth factor receptor 1 (FGFR1) is a potential treatment for squamous cell lung cancer (SQCLC). So far, treatment decision in clinical studies is based on gene amplification. However, only a minority of patients have shown durable response. Furthermore, former studies have revealed contrasting results regarding the impact of FGFR1 amplification and expression on patient's prognosis. AIMS: Here, we analyzed prevalence and correlation of FGFR1 gene amplification and protein expression in human lung cancer and their impact on overall survival. MATERIALS & METHODS: FGFR1 gene amplification and protein expression were analyzed by fluorescence in situ hybridization and immunohistochemistry (IHC) in 208 SQCLC and 45 small cell lung cancers (SCLC). Furthermore, FGFR1 protein expression was analyzed in 121 pulmonary adenocarcinomas (ACs). Amplification and expression were correlated to each other, clinicopathological characteristics, and overall survival. RESULTS: FGFR1 was amplified in 23% of SQCLC and 8% of SCLC. Amplification was correlated to males (P = .027) but not to overall survival. Specificity of immunostaining was verified by cellular CRISPR/Cas9 FGFR1 knockout. FGFR1 was strongly expressed in 9% of SQCLC, 35% of AC, and 4% of SCLC. Expression was correlated to females (P = .0187) and to the absence of lymph node metastasis in SQCLC (P = .018) with no significant correlation to overall survival. Interestingly, no significant correlation between amplification and expression was detected. DISCUSSION: FGFR1 gene amplification does not seem to correlate to protein expression. CONCLUSION: We believe that patient selection for FGFR1 inhibitors in clinical studies should be reconsidered. Neither FGFR1 amplification nor expression influences patient's prognosis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos / Carcinoma Pulmonar de Células Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos / Carcinoma Pulmonar de Células Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos